Trials / Unknown
UnknownNCT03396523
Losartan and Emotion Processing
Losartan Effects on the Extinction of Conditioned Fear in Humans
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to investigate the effect of losartan (50mg, single dose) on the extinction of conditioned fear
Detailed description
In a double-blind, between-subject, placebo controlled design the effects of a single dose of losartan (50mg) on fear extinction in healthy male participants will be examined. Participants will initially undergo a Pavlovian fear conditioning procedure, followed by the administration of 50mg losartan or placebo. 90 minutes after treatment subjects will undergo the fear extinction procedure. Neural activity and psychophysiological indices of arousal will be assessed by the simultaneous acquisition of functional magnetic resonance imaging (fMRI) and skin conductance data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan | administration of losartan (50 mg) (oral) |
| DRUG | Placebo Oral Tablet | administration of placebo (oral) |
Timeline
- Start date
- 2018-01-04
- Primary completion
- 2018-10-31
- Completion
- 2018-12-31
- First posted
- 2018-01-11
- Last updated
- 2018-06-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03396523. Inclusion in this directory is not an endorsement.